Barclays Initiates Coverage On Amrize with Equal-Weight Rating, Announces Price Target of $55
Barclays analyst Adam Seiden initiates coverage on Amrize (NYSE:AMRZ) with a Equal-Weight rating and announces Price Target of $55.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga